NEW YORK (dpa-AFX) – At the end of a strong month, Wall Street investors took profits in early Monday trading. The leading index Dow Jones Industrial fell after one hour of trading by 1.33 percent to 29,511.23 points. This moved him further away from the 30,000 point mark that he had left behind for the first time the previous week. In these spheres, investors had recently got cold feet again.
What remains is a strong November. Shaped first by the US election and then even more by the vaccine news, the Dow is up 11.4 percent this month. Since Biontech and Pfizer stirred up euphoria on November 9th, the annual balance for the leading index has also become positive again. Regardless of the virus crisis, a Dow gain of 3.4 percent is currently emerging for the Corona year 2020.
With the leading Wall Street index, the other New York indices were also in reverse on Monday. The broad S&P 500 fell 0.97 percent to 3603.00 points in early trading, while the tech-heavy Nasdaq 100 fell 0.79 percent to 12,160.94 points.
At the beginning of the week, the focus was once again on the developers of corona vaccines – with a broad rally that also took hold of the Novavax shares, despite what appears to be bad news. The papers advanced by a further eight percent, even if the company announced a delay of several weeks in the crucial study for its own vaccine candidate.
Novavax is still a bit away from course records, unlike corporations such as Moderna, Biontech or Curevac. Their shares were on Monday with price jumps between 7.7 percent and 14.8 percent as expensive as never before. Moderna had announced that approval for a corona vaccine in the EU should also be applied for this Monday. At Biontech, there is now speculation about a very quick approval in Great Britain.
Aside from the coronavirus situation, the prospect of takeovers heated tempers. S&P Global wants to take over competitor IHS Markit in a 44 billion US dollar share deal. While the Markit titles gained about eight percent, those of S&P Global brought it to a plus of 2.7 percent.
Meanwhile, a possible Salesforce bid for Slack also provides further topics of conversation. An increase of 4.2 percent catapulted them over the previous record of 42 dollars, which came from the day of the IPO in June 2019. As the business broadcaster CNBC reported, citing circles, an offer could come on Tuesday. For Salesforce shares, it then went down 3.6 percent at the end of the Dow to its lowest level since early November.
Records were also popular at Tesla, with shares jumping above the $ 600 mark for the first time since their share split in August. But then profit-taking quickly set in, most recently the papers were traded at four percent in the red.
Nikola papers, on the other hand, collapsed by 26 percent. The electric car start-up, which was traded as a Tesla competitor, had admitted that General Motors would not initially participate in the plan. GM stocks fell nearly three percent./tih/he
– .
